| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 26, 2006
Accepted on February 14, 2007
From the Department of Biochemistry (Y.S.P., Y.M., R.T., M.T., N.T.) and the Department of Disease Glycomics, Research Institute for Microbial Diseases (N.T.), Osaka University, Japan; the Department of Microbiology (Y.S.P.), College of Medicine, Kyung Hee University, Seoul, Korea; and the Urological Diseases Research Center (J.K., M.R.F.), Children’s Hospital Boston, Harvard Medical School, Boston, Mass.
* To whom correspondence should be addressed. E-mail: tani52{at}wd5.so-net.ne.jp.
Objective--Acrolein, a known toxin in tobacco smoke, might be involved in atherogenesis. This study examined the effect of acrolein on expression of cyclooxygenase-2(COX-2) and prostaglandin (PG) production in endothelial cells.
Methods and Results--Cyclooxygenase (COX)-2 induction by acrolein and signal pathways were measured using Western blots, Northern blots, immunoflouresence, ELISA, gene silencing, and promoter assay. Colocalization of COX2 and acrolein-adduct was determined by immunohistochemistry. Here we report that the levels of COX-2 mRNA and protein are increased in human umbilical vein endothelial cells (HUVECs) after acrolein exposure. COX-2 was found to colocalize with acrolein-lysine adducts in human atherosclerotic lesions. Inhibition of p38 MAPK activity abolished the induction of COX-2 protein and PGE2 accumulation by acrolein, while suppression of extracellular signal-regulated kinase (ERK) and JNK activity had no effect on the induction of COX-2 expression in experiments using inhibitors and siRNA. Furthermore, rottlerin, an inhibitor of protein kinase C
(PKC
), abrogated the upregulation of COX-2 at both protein and mRNA levels.
Conclusion--These results provide that acrolein may play a role in progression of atherosclerosis and new information on the signaling pathways involved in COX-2 upregulation in response to acrolein and provide evidence that PKC
and p38 MAPK are required for transcriptional activation of COX-2.
This article has been cited by other articles:
![]() |
C.-M. Yang, I-T. Lee, C.-C. Lin, Y.-L. Yang, S.-F. Luo, Y. R. Kou, and L.-D. Hsiao Cigarette smoke extract induces COX-2 expression via a PKC{alpha}/c-Src/EGFR, PDGFR/PI3K/Akt/NF-{kappa}B pathway and p300 in tracheal smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L892 - L902. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, Y. Liu, L. Chen, X. Wang, X-R. Hu, Y-L. Feng, D-S. Liu, D. Xu, Y-P. Duan, J. Lin, et al. Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats Eur. Respir. J., May 1, 2009; 33(5): 1122 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamawaki, K. Saito, M. Okada, and Y. Hara Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1510 - C1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Lamon and D. P. Hajjar Inflammation at the Molecular Interface of Atherogenesis: An Anthropological Journey Am. J. Pathol., November 1, 2008; 173(5): 1253 - 1264. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |